Glioma

You have access
Re-irradiation for Recurrent Primary Brain Tumors
CARSTEN NIEDER, NICOLAUS H. ANDRATSCHKE and ANCA L. GROSU

Anticancer Research October 2016, 36 (10) 4985-4995;
You have access
Non-routine Tracers for PET Imaging of High-grade Glioma
GUIDO FROSINA

Anticancer Research July 2016, 36 (7) 3253-3260;
You have access
In Vitro Validation of Intratumoral Modulation Therapy for Glioblastoma
HU XU, FRANK BIHARI, SHAWN WHITEHEAD, EUGENE WONG, SUSANNE SCHMID and MATTHEW O. HEBB

Anticancer Research January 2016, 36 (1) 71-80;
You have access
Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine
TOKUNBO YEROKUN and LEYTE L. WINFIELD

Anticancer Research December 2015, 35 (12) 6419-6424;
You have access
Evidence of ¹⁸F-FCH Uptake in Human T98G Glioblastoma Cells
FEDERICA ELEONORA BURONI, FRANCESCA PASI, MARCO GIOVANNI PERSICO, LORENZO LODOLA, CARLO APRILE and ROSANNA NANO

Anticancer Research December 2015, 35 (12) 6439-6443;
You have access
Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells
KATHERINE A. SCOTT, JAYNE L. DENNIS, ANGUS G. DALGLEISH and WAI M. LIU

Anticancer Research November 2015, 35 (11) 5827-5837;
You have access
MR Spectroscopic Profile of an Angiocentric Glioma
MATTHEW T. WHITEHEAD and GILBERT VEZINA

Anticancer Research November 2015, 35 (11) 6267-6270;
You have access
Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma
JOHNNY DUERINCK, STEPHANIE DU FOUR, WILHELM SANDER, ANNE-MARIE VAN BINST, HENDRIK EVERAERT, ALEX MICHOTTE, PETER HAU and BART NEYNS

Anticancer Research October 2015, 35 (10) 5551-5557;
You have access
Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors
ALI KAFADAR, ÖZLEM KÜÇÜKHÜSEYIN, SAIME TURAN, EZGI NURDAN YENILMEZ, SERVET TUNOGLU, UMIT ZEYBEK, MEHMET YASAR KAYNAR, RAHSAN KEMERDERE and ILHAN YAYLIM

Anticancer Research July 2015, 35 (7) 3933-3942;
You have access
Relationships Between Dose Intensity, Toxicity, and Outcome in Patients with Oligodendroglial Tumors Treated with the PCV Regimen
EMELINE TABOURET, GERMAN REYES-BOTERO, CAROLINE DEHAIS, MARINE DAROS, MARYLINE BARRIE, MONA MATTA, GREGORIO PETRIRENA, DIDIER AUTRAN, ALBERTO DURAN, CELINE BEQUET, JEAN-YVES DELATTRE and OLIVIER CHINOT

Anticancer Research May 2015, 35 (5) 2901-2908;

Main menu

User menu

Search

Glioma

Pages